Matrix metallopeptidase 2 activity in tendon regions: effects of mechanical loading exercise associated to anabolic-androgenic steroids.
Matrix metallopeptidases (MMPs) are responsible for degradation of the extracellular matrix components and tissue remodeling. To achieve a better understanding of AAS effects in rat tendon, MMP-2 activity in the proximal and distal regions of the calcanear tendon (CT) and proximal, intermediate and distal region of superficial (SFT) and deep flexor tendons (DFT) after mechanical load exercise associated with AAS was investigated. Animals were grouped into four groups: sedentary animals (S); sedentary animals with ASS supplementation (S + A); trained animals (T) and trained animals with AAS supplementation (T + A). Analysis of MMP activity in tendon extracts was done by gelatin zymography. Both proximal and distal regions of the calcanear tendon showed the lowest MMP-2 concentration and the highest proportion in MMP-2 active form. The intermediate region of the SFT differed (P < 0.01) from the proximal and distal regions with higher % of active MMP-2 in the sedentary group. The proportion of active MMP-2 decreased in the proximal region of the CT. AAS treatment strongly decreased both MMP-2 concentration and active form in the three regions of the SFT and on the proximal region of the CT, but not on the DFT. The differences in the response to exercise and AAS treatment are a result of distinct metabolism and recruitment of these tendon regions in the exercise program employed in this study.
Marqueti
Rita C
RC
Department of Physiological Sciences, Federal University of São Carlos (UFSCar), São Paulo, Brazil. marqueti@gmail.com
Prestes
Jonato
J
Paschoal
Milena
M
Ramos
Oscar H P
OH
Perez
Sérgio E A
SE
Carvalho
Hernandes F
HF
Selistre-de-Araujo
Heloisa S
HS
D045930:Anabolic Agents / Q000494:pharmacology*; D000818:Animals; D001696:Biomechanical Phenomena; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D009277:Nandrolone / Q000031:analogs & derivatives / Q000494:pharmacology; D000077603:Nandrolone Decanoate; D010805:Physical Conditioning, Animal / Q000502:physiology*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013256:Steroids / Q000494:pharmacology*; D013710:Tendons / Q000187:drug effects / Q000378:metabolism*; D045165:Testosterone Congeners / Q000494:pharmacology; D016474:Weight-Bearing / Q000502:physiology*
D045930:Anabolic Agents; D013256:Steroids; D045165:Testosterone Congeners; D009277:Nandrolone; D020778:Matrix Metalloproteinase 2; D000077603:Nandrolone Decanoate